The Business of Living Longer

​ Longevity has moved from fringe to front page. Large raises are being announced, companies are being built, and physicians are rethinking what preventive care actually means.

​On May 4th, Forum Ventures and Mount Sinai Innovation Partners are hosting a private breakfast in New York City to have that conversation — a discussion between all stakeholders in the business of longevity and preventative care.

​You'll hear from investors alongside physicians, industry experts, and founders building at the frontier of this space.

​​​​​​Request a spot to join and get access to the location.

​We'll be exploring

• ​What's real, what's hype, and where is the smart money actually going?

• ​Where are the real growth and investment opportunities in longevity?

​Speakers

​Nikhil Krishnan, Founder @ Out-Of-Pocket

​Nikhil is the Founder of Out-Of-Pocket, a healthcare media, education, and investing platform that uses humor, memes, and accessible language to demystify the business of healthcare. Out-Of-Pocket is read by 30,000+ healthcare professionals and praised by CMOs, CEOs, and senior healthcare executives for being both rigorous and genuinely entertaining.

​Emma Silverman, Partner @ TMV

​Emma is a Partner at TMV, where she leads the firm's Health + Bio practice. Shaped by a family deeply rooted in medicine and a career spent building companies from the ground up, she brings personal conviction and operator experience to the founders she backs.

​Ramin Sahebjavaher, PhD, Founder @ Anomaly Health

​Ramin is the Founder and CEO of Anomaly Health. Anomaly is building proactive health intelligence and orchestration for people who want a clearer, more actionable approach to longevity and prevention. Dr. Ramin Sahebjavaher is a serial entrepreneur and biomedical engineer with a PhD in Biomedical Engineering from the University of British Columbia.

​Zahi Fayad, PhD, Director, BioMedical Engineering & Imaging Institute @ Mount Sinai

​Zahi is a world-renowned biomedical engineer and imaging scientist at the Icahn School of Medicine at Mount Sinai. He holds the Lucy G. Moses Professorship in Medical Imaging and Bioengineering, serves as a Professor of Radiology and Medicine (Cardiology), and is the founding Director of the BioMedical Engineering and Imaging Institute (BMEII),one of the most prominent research centers of its kind.

​Miriam Merad, MD, PhD, Director of Precision Immunology Institute @ Icahn School of Medicine at Mount Sinai

​Miriam is one of the world's leading immunologists and a pioneering physician-scientist at the Icahn School of Medicine at Mount Sinai. She holds the Robin Chemers Neustein Professorship and the Mount Sinai Professorship in Cancer Immunology, and currently serves as Dean for Translational Research and Therapeutic Innovation, Founding Chair of the Department of Immunology and Immunotherapy, and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM).

​Ideal Guests

​Investors, physicians, founders, and operators with a stake in the longevity and preventive care landscape.

​Approved Guests

​​​​Application DOES NOT guarantee attendance. ​​Spaces for this event are limited to maintain the quality of interactions and aim to ensure every participant receives optimum value.

​​​​Admitted guests will be notified via event approval (with a calendar invite).

​​About Forum Ventures

​​​​​​Forum Ventures is the leading early-stage fund, accelerator and AI venture studio for B2B startups. Founded in 2014, we’re on a mission to make the journey easier, more accessible, and successful for early-stage founders.

​​​​​​Forum is investing in 85 startups this year. Pitch Us here.

​​​We’re also launching 8 new companies in our venture studio. If you’ve lived a real pain point and have an idea you’re ready to build, tell us why you’d be a great founder for our AI Venture Studio.

​​About Mount Sinai Innovation Partners

​Mount Sinai Innovation Partners (MSIP) facilitates the real-world application and commercialization of Mount Sinai Heath System discoveries and the development of research partnerships.

​​​​Brought to you by Brown Rudnick

​Brown Rudnick is an international law firm with over 75 years of experience, specializing in high-stakes litigation, crisis management, and complex business transactions for tech and life sciences clients.

​Founded in 1948 with roots in Boston and New York, it has expanded to include London and other key U.S. cities, operating with roughly 225 attorneys.